HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Salles Selected Research

ACE protocol 2

12/2000A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Salles Research Topics

Disease

17Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2017 - 06/2000
17Lymphoma (Lymphomas)
12/2017 - 01/2000
14Neoplasms (Cancer)
04/2022 - 07/2000
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2016 - 09/2000
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2017 - 01/2001
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2016 - 11/2002
4Pathologic Complete Response
04/2015 - 12/2000
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2013 - 09/2000
3Multiple Myeloma
04/2022 - 07/2000
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2007 - 06/2001
3Neutropenia
05/2004 - 01/2000
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
11/2002 - 02/2000
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
07/2021 - 01/2018
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2018 - 03/2006
2Renal Insufficiency (Renal Failure)
12/2017 - 01/2011
2Necrosis
07/2016 - 02/2004
2Hodgkin Disease (Hodgkin's Disease)
02/2016 - 05/2004
2Residual Neoplasm
10/2012 - 07/2000
2Infections
10/2012 - 07/2000
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2011 - 03/2006
1Splenic Infarction
03/2020
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2018
1Ototoxicity
12/2017
1Sarcoidosis (Schaumann Disease)
11/2017
1Graft vs Host Disease (Graft-Versus-Host Disease)
07/2016
1Toxoplasmosis
07/2016
1Disease Progression
04/2015
1Drug-Related Side Effects and Adverse Reactions
04/2015
1Hemorrhagic Cystitis
05/2014
1Water Intoxication
01/2011
1Cardiomyopathies (Cardiomyopathy)
05/2004
1Cardiotoxicity
05/2004
1Overweight
05/2004
1Hypertension (High Blood Pressure)
05/2004
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
05/2004
1Heart Diseases (Heart Disease)
05/2004
1Thrombocytopenia (Thrombopenia)
07/2003
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
07/2003
1Primary Myelofibrosis (Myelosclerosis)
03/2003
1Mucositis
12/2002
1Vomiting
12/2002
1Familial primary gastric lymphoma
09/2002

Drug/Important Bio-Agent (IBA)

12Rituximab (Mabthera)FDA Link
03/2016 - 01/2001
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2008 - 01/2000
5Biological ProductsIBA
03/2020 - 02/2000
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2008 - 01/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2004 - 01/2000
4Cytarabine (Cytosar-U)FDA LinkGeneric
12/2017 - 08/2000
3Carmustine (FIVB)FDA Link
07/2017 - 08/2000
3Monoclonal AntibodiesIBA
03/2016 - 01/2001
3Melphalan (Alkeran)FDA LinkGeneric
02/2016 - 07/2000
3Etoposide (VP 16)FDA LinkGeneric
02/2016 - 08/2000
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2017 - 07/2017
2Pharmaceutical PreparationsIBA
04/2015 - 01/2011
2Vincristine (Oncovin)FDA LinkGeneric
10/2008 - 06/2005
2AnthracyclinesIBA
10/2008 - 05/2004
2Prednisone (Sone)FDA LinkGeneric
10/2008 - 06/2005
2Proteins (Proteins, Gene)FDA Link
03/2008 - 03/2001
2Complementary DNA (cDNA)IBA
03/2006 - 11/2002
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2001 - 12/2000
2LigandsIBA
11/2000 - 01/2000
1Immunologic Factors (Immunomodulators)IBA
04/2022
1Immunomodulating AgentsIBA
04/2022
1Anaplastic Lymphoma KinaseIBA
01/2018
1Carboplatin (JM8)FDA LinkGeneric
12/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2017
1SaltsIBA
12/2017
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2017
1Cisplatin (Platino)FDA LinkGeneric
12/2017
1PlatinumIBA
12/2017
1Histone MethyltransferasesIBA
01/2017
1Etanercept (Enbrel)FDA Link
07/2016
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
02/2016
1Chlorambucil (Leukeran)FDA Link
01/2016
1Antineoplastic Agents (Antineoplastics)IBA
04/2015
1Lenalidomide (CC 5013)FDA Link
01/2013
1Proton Pump InhibitorsIBA
01/2011
1Leucovorin (Folinic Acid)FDA Link
01/2011
1Methotrexate (Mexate)FDA LinkGeneric
01/2011
1gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA
01/2011
1MicroRNAs (MicroRNA)IBA
09/2009
1Biomarkers (Surrogate Marker)IBA
02/2009
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2008
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2007
1IgKIBA
02/2007
1Immunoglobulins (Immunoglobulin)IBA
02/2007
1Biological FactorsIBA
10/2005
1Transcription Factors (Transcription Factor)IBA
02/2004
1Amifostine (Ethyol)FDA LinkGeneric
12/2002

Therapy/Procedure

12Stem Cell Transplantation
07/2021 - 06/2000
12Drug Therapy (Chemotherapy)
12/2017 - 01/2000
10Therapeutics
01/2018 - 06/2000
4Transplantation
07/2003 - 07/2000
3Hematopoietic Stem Cell Transplantation
07/2017 - 10/2012
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2003 - 06/2000
1Cell Transplantation
07/2016
1Immunotherapy
09/2012
1Radiotherapy
05/2004
1Splenectomy
03/2003
1Heart Transplantation (Grafting, Heart)
09/2002